Taro Pharmaceuticals Inc
General
Total Cases15
Active Cases1
Patents--
Ratings
Experience
Grade
Trend
DCT
L5
E
PTAB
L4
A
CAFC
L4
C
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 07/08/24 | CONSENT JUDGMENT AND ORDER OF PERMANENT INJUNCTION. Signed by Judge Michael A. Shipp on 7/3/2024. (amv) (Entered: 07/08/2024) | |
| 06/24/24 | Letter from Charles H. Chevalier, Esq. to the Honorable Michael A. Shipp, U.S.D.J.. (Attachments: # [1] Consent Judgment and Order of Permanent Injunction)(CHEVALIER, CHARLES) (Entered: 06/24/2024) | |
| 06/20/24 | LETTER ORDER granting a three-week extension until 7/11/2024, to submit a proposed discovery confidentiality order. Signed by Magistrate Judge Tonianne J. Bongiovanni on 6/20/2024. (kht) (Entered: 06/20/2024) | |
| 06/20/24 | Letter from Charles H. Chevalier to The Honorable Tonianne J. Bongiovanni, U.S.M.J. (CHEVALIER, CHARLES) (Entered: 06/20/2024) | |
| 06/14/24 | LETTER ORDER Granting [22] request for a one-week extension until 6/20/2024, to submit a proposed Discovery Confidentiality Order. Signed by Magistrate Judge Tonianne J. Bongiovanni on 6/14/2024. (amv) (Entered: 06/14/2024) | |
| 06/13/24 | Letter from Charles H. Chevalier, Esq. to the Honorable Tonianne J. Bongiovanni, U.S.M.J.. (CHEVALIER, CHARLES) (Entered: 06/13/2024) | |
| 05/17/24 | LETTER ORDER Setting a schedule following the Initial Conference. Signed by Magistrate Judge Tonianne J. Bongiovanni on 5/17/2024. (amv) (Entered: 05/17/2024) | |
| 05/01/24 | ANSWER to Counterclaim by GALDERMA HOLDING, S.A., GALDERMA LABORATORIES, L.P., GALDERMA RESEARCH & DEVELOPMENT, S.N.C., GALDERMA S.A..(CHEVALIER, CHARLES) (Entered: 05/01/2024) | |
| 05/01/24 | Text Minute Entry for proceedings held before Magistrate Judge Tonianne J. Bongiovanni: Initial Pretrial Conference held on 4/30/2024. (jem) (Entered: 05/01/2024) | |
| 04/30/24 | Pro Hac Vice fee: Charles B. Klein, Jovial Wong, Kevin Boyle and Elise M. LeCrone $ 1000.00, receipt number TRE138282. (mlh) (Entered: 04/30/2024) |